The EDC is live today — see what ships now
All studies
NCT07714044From ClinicalTrials.govRecruiting

Rutgers University Study of the Genetics of Blood Cancers

The Rutgers University Study of the Genetics of Blood Cancers

  • Blood Cancers
  • Blood Cancer
  • Leukemia
  • Lymphoma
  • Myeloma
  • Hematologic Cancer
  • Hematologic Malignancies
  • Hematologic Neoplasm

At a glance

Phase
Phase not stated
Study type
Observational
Sponsor
Rutgers, The State University of New Jersey
Enrolment target
10,000
Started
22 September 2026
Main results due
August 2029
Study sites
1
Registry updated
25 September 2026

Can you take part?

  • Ages 18 years to 110 years.
  • Open to any sex.
  • Healthy volunteers can take part.

These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.

Read the full eligibility criteria
Inclusion Criteria:

* age 18 years or older
* currently living in the United States
* have access to the internet and a computer, laptop, tablet or smartphone
* willing to provide written informed consent for participation
* willing to provide DNA via a saliva sample using a collection kit mailed to your home
* willing to complete a survey with questions about health related to the study of blood cancer.

Exclusion Criteria:

* Not able to meet or fulfill any of the inclusion criteria

What this study is about

In the sponsor’s own words, from the registry.

The goal of this study is to enroll at least 10,000 participants nationally including affecteds and unaffecteds via online study portal, collect surveys online and a saliva sample through the mail, sequence DNA, and conduct genetic analyses to identify novel variants and further study known variants associated with leukemia, lymphoma, myeloma and other blood cancers.

Study sites(1)

  • Rutgers University

    Piscataway, New Jersey, United States

    Recruiting

Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.

Source: ClinicalTrials.gov record NCT07714044. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Not the right study?

Answer three questions and see the studies recruiting near you, in plain language.

Find a study for me
Rutgers University Study of the Genetics of Blood Cancers | Trialion